---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-159793"
form_type: "8-K"
ticker: "RANI"
cik: "0001856725"
company_name: "Rani Therapeutics Holdings, Inc."
filed_at: "2025-07-16T23:59:59+00:00"
generated_at: "2026-05-18T06:18:41.604789+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Rani Therapeutics raises $3.0M via stock and warrant offering; suspends ATM facility

## Summary
- Entered securities purchase agreement to issue 4.354M shares and 3.146M pre-funded warrants at $0.40/share.
- Gross proceeds expected to be ~$3.0M; closing expected on July 16, 2025.
- Suspended its Controlled Equity Offering ATM program with H.C. Wainwright.
- Directors and officers entered into 45-day lock-up agreements.
- Placement agent Maxim Group LLC receives 5.25% cash fee.

## SEC filing metadata
- accession: 0001193125-25-159793
- form_type: 8-K
- ticker: RANI
- cik: 0001856725
- company_name: Rani Therapeutics Holdings, Inc.
- filed_at: 2025-07-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1856725/000119312525159793/0001193125-25-159793-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1856725/000119312525159793/d917538d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-159793
- JSON: https://secwatch.observer/filing/0001193125-25-159793.json
- Plain text: https://secwatch.observer/filing/0001193125-25-159793.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.